Embecta Corp is a healthcare company based in the United States of America with an ESG score of 26.7, indicating a medium risk assessment. Specializing in medical technology, Embecta Corp develops cutting-edge solutions that enhance clinical therapy for patients and streamline healthcare processes for providers. Their product lineup features BD Pyxis, PureWick, Phasix, and more.